For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the emergence of this treatment and the read more formulated version represents a true advancement . These novel therapies preserve the transthyretin protein, slowing its harmful build-up and alleviating the burden of the illness. Individuals are now exper